title: Antipsychotic treatment discontinuation among individuals with schizophrenia and co-occurring substance use.
authors.forename: David A
authors.initials: DA
authors.lastname: Smelson
authors.forename: Sandra L
authors.initials: SL
authors.lastname: Tunis
authors.forename: Allen W
authors.initials: AW
authors.lastname: Nyhuis
authors.forename: Douglas E
authors.initials: DE
authors.lastname: Faries
authors.forename: Bruce J
authors.initials: BJ
authors.lastname: Kinon
authors.forename: Haya
authors.initials: H
authors.lastname: Ascher-Svanum
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use; D006801:Humans; D000077152:Olanzapine; D010352:Patient Dropouts; D018967:Risperidone / Q000627:therapeutic use; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy*; D019966:Substance-Related Disorders / Q000150:complications*; D013997:Time Factors; D016896:Treatment Outcome; D016312:Treatment Refusal
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D018967:Risperidone; D000077152:Olanzapine